These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 24577935
1. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. D'Aoust J, Hudson M, Tatibouet S, Wick J, Canadian Scleroderma Research Group, Mahler M, Baron M, Fritzler MJ. Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935 [Abstract] [Full Text] [Related]
2. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma. Maes L, Blockmans D, Verschueren P, Westhovens R, De Beéck KO, Vermeersch P, Van den Bergh K, Burlingame RW, Mahler M, Bossuyt X. Clin Chim Acta; 2010 Jul 04; 411(13-14):965-71. PubMed ID: 20346932 [Abstract] [Full Text] [Related]
4. The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort. Lazzaroni MG, Marasco E, Campochiaro C, DeVries-Bouwstra J, Gonzalez-Perez MI, Rojas-Serrano J, Hachulla E, Zanatta E, Barsotti S, Furini F, Triantafyllias K, Abignano G, Truchetet ME, De Luca G, De Langhe E, Hesselstrand R, Ingegnoli F, Bertoldo E, Smith V, Bellando-Randone S, Poormoghim H, Colombo E, Ceribelli A, Furloni A, Zingarelli S, Cavazzana I, Franceschini F, Del Galdo F, Denton CP, Cavagna L, Distler O, Allanore Y, Airò P, EUSTAR co-authors. Rheumatology (Oxford); 2021 Nov 03; 60(11):5028-5041. PubMed ID: 33580257 [Abstract] [Full Text] [Related]
5. Anti-PM-Scl antibody in patients with systemic sclerosis. Koschik RW, Fertig N, Lucas MR, Domsic RT, Medsger TA. Clin Exp Rheumatol; 2012 Nov 03; 30(2 Suppl 71):S12-6. PubMed ID: 22261302 [Abstract] [Full Text] [Related]
6. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques. Bonroy C, Smith V, Van Steendam K, Van Praet J, Deforce D, Devreese K, De Keyser F. Clin Exp Rheumatol; 2012 Nov 03; 30(5):748-55. PubMed ID: 22765957 [Abstract] [Full Text] [Related]
7. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis. Patterson KA, Roberts-Thomson PJ, Lester S, Tan JA, Hakendorf P, Rischmueller M, Zochling J, Sahhar J, Nash P, Roddy J, Hill C, Nikpour M, Stevens W, Proudman SM, Walker JG. Arthritis Rheumatol; 2015 Dec 03; 67(12):3234-44. PubMed ID: 26246178 [Abstract] [Full Text] [Related]
8. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody. Guillen-Del Castillo A, Pilar Simeón-Aznar C, Fonollosa-Pla V, Alonso-Vila S, Reverte-Vinaixa MM, Muñoz X, Pallisa E, Selva-O'allaghan A, Fernández-Codina A, Vilardell-Tarrés M. Semin Arthritis Rheum; 2014 Dec 03; 44(3):331-7. PubMed ID: 25110305 [Abstract] [Full Text] [Related]
9. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Hanke K, Brückner CS, Dähnrich C, Huscher D, Komorowski L, Meyer W, Janssen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester GR, Hiepe F, Schlumberger W, Riemekasten G. Arthritis Res Ther; 2009 Dec 03; 11(1):R22. PubMed ID: 19220911 [Abstract] [Full Text] [Related]
12. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies. Airo' P, Ceribelli A, Cavazzana I, Taraborelli M, Zingarelli S, Franceschini F. J Rheumatol; 2011 Jul 03; 38(7):1329-34. PubMed ID: 21459934 [Abstract] [Full Text] [Related]
13. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis. Bonroy C, Van Praet J, Smith V, Van Steendam K, Mimori T, Deschepper E, Deforce D, Devreese K, De Keyser F. J Immunol Methods; 2012 May 31; 379(1-2):53-60. PubMed ID: 22446156 [Abstract] [Full Text] [Related]
14. Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Tatibouet S, Wang M, Canadian Scleroderma Research Group (CSRG), Australian Scleroderma Interest Group (ASIG), Genetics versus Environment in Scleroderma Outcome Study (GENISOS), Baron M, Fritzler MJ. Autoimmunity; 2015 May 31; 48(8):542-51. PubMed ID: 26334795 [Abstract] [Full Text] [Related]
15. Is the measurement of anti-PM-1α antibodies at least as important as that of other systemic sclerosis-specific antibodies? Comment on the article by D'Aoust et al. Muro Y, Sugiura K, Akiyama M. Arthritis Rheumatol; 2014 Nov 31; 66(11):3248. PubMed ID: 25077816 [No Abstract] [Full Text] [Related]
16. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. Santiago M, Baron M, Hudson M, Burlingame RW, Fritzler MJ. J Rheumatol; 2007 Jul 31; 34(7):1528-34. PubMed ID: 17610318 [Abstract] [Full Text] [Related]
17. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma. Schnitz W, Taylor-Albert E, Targoff IN, Reichlin M, Scofield RH. J Rheumatol; 1996 Oct 31; 23(10):1729-33. PubMed ID: 8895149 [Abstract] [Full Text] [Related]
20. Anti-SSA/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study. Sánchez-Montalvá A, Fernández-Luque A, Simeón CP, Fonollosa-Plà V, Marín A, Guillén A, Vilardell M. Clin Exp Rheumatol; 2014 Oct 31; 32(6 Suppl 86):S-177-82. PubMed ID: 25372801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]